On December 6, 2019, the FDA warned Liveyon Labs Inc. (“Liveyon Labs”) and Liveyon LLC for processing and distributing unapproved products derived from umbilical cord blood (PURE and PURE PRO). The FDA further warned the companies regarding significant deviations from… Read More
-
FDA Seeks Injunction Against Two Stem Cell Clinics For Alleged Marketing And Safety Violations
The FDA filed a federal lawsuit on May 9, 2018 seeking a permanent injunction against two stem cell clinics to require that they cease marketing their stem cell products until, among other things, they obtain necessary FDA approvals and correct… Read More
